Lymphocyte subpopulations: a potential predictor of a response in patients with immune thrombocytopenia-Reference-Cited by-同舟云学术

Lymphocyte subpopulations: a potential predictor of a response in patients with immune thrombocytopenia

Published:2024-01-22 Issue:1 Volume:29 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Žibřidová Kateřina¹²^ORCID,Souček Ondřej³⁴^ORCID,Krčmová Lenka Kujovská⁵^ORCID,Jankovičová Karolína³⁴,Gančarčíková Markéta⁵,Pejková Mária Anna¹²,Drugda Jan¹²,Nováková Denisa¹²,Košťál Milan¹²^ORCID

Affiliation:

1. 4th Department of Internal Medicine - Hematology, University Hospital Hradec Králové, Hradec Králové, Czech Republic

2. Academic Department of Internal Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic

3. Department of Clinical Immunology and Allergology, University Hospital Hradec Králové, Hradec Králové, Czech Republic

4. Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic

5. Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic

Funder

Ministerstvo Zdravotnictví Ceské Republiky

Cooperatio research program - area ONCO

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2024.2304486

Reference26 articles.

1. American Society of Hematology 2019 guidelines for immune thrombocytopenia

2. Biomarkers for immune thrombocytopenia

3. Can Immune Thrombocytopenia Be Cured with Medical Therapy?

4. Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

5. Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia ( ITP ) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies